Literature DB >> 32377242

THYROID SURGERY, IONM AND SUGAMMADEX SODIUM RELATIONSHIPS: BENEFITS IN SUGAMMADEX SODIUM USE FOR IONM.

T Donmez1, V M Erdem2, O Sunamak3, H Ozcevik4.   

Abstract

BACKGROUND: It is important to protect recurrent laryngeal nerve (RLN) during thyroid surgery. Thus, intra- operative neuromonitoring (IONM) has got popularity. But, the half life of neuromuscular blocking agents used has a reverse correlation with reliability and effectiveness of IONM. This study aimed to research the effect of Sugammadex Sodium, a specific nemuromuscular blocking agent antagonist, on nerve conduction and IONM.
MATERIALS AND METHODS: Twenty patients who underwent thyroidectomy under IONM followed an enhanced NMB recovery protocol-rocuronium 0.6 mg/kg at anesthesia induction and sugammadex 2 mg/kg at the beginning of operation. To prevent laryngeal nerve injury during the surgical procedures, all patients underwent intraoperative monitoring. At the same time, the measurement of TOF-Watch acceleromyograph of the adductor pollicis muscle response to ulnar nerve stimulation was performed; recovery was defined as a train-of-four (TOF) ratio ≥ 0.9. Age, sex, recurrent laryngeal nerve transmission speeds prior to and after operation, BMI, duration of surgery, the change in nerve transmission after drug administration and complications were analyzed.
RESULTS: The mean age and the mean BMI were 47.6±11.82 years and 28.74±3.20, respectively. The mean operation duration was 52.65±5.51 minutes. There was no difference in either right or left RLN monitoring values before and after surgery. Following the drug injection, the TOF guard measurements on the 1st, 2nd, 3rd and 4th minutes were 23.5±4.90; 69.5±6.86; 88±4.1 and 135.9±10.62, respectively.
CONCLUSION: Neuromuscular blocking antagonist use and monitoring nerve transmission speed with TOF-guard can provide a safer resection. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  TOF guard; intraoperative nerve monitoring; thyroidectomy

Year:  2019        PMID: 32377242      PMCID: PMC7200106          DOI: 10.4183/aeb.2019.454

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  33 in total

1.  Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk.

Authors:  Martin Steurer; Christian Passler; Doris M Denk; Berit Schneider; Bruno Niederle; Wolfgang Bigenzahn
Journal:  Laryngoscope       Date:  2002-01       Impact factor: 3.325

2.  Detecting and identifying nonrecurrent laryngeal nerve with the application of intraoperative neuromonitoring during thyroid and parathyroid operation.

Authors:  Feng-Yu Chiang; I-Cheng Lu; Cheng-Jing Tsai; Pi-Jung Hsiao; Ka-Wo Lee; Che-Wei Wu
Journal:  Am J Otolaryngol       Date:  2011-02-08       Impact factor: 1.808

3.  Vagal nerve stimulation without dissecting the carotid sheath during intraoperative neuromonitoring of the recurrent laryngeal nerve in thyroid surgery.

Authors:  Che-Wei Wu; Gianlorenzo Dionigi; Hui-Chun Chen; Hsiu-Ya Chen; Ka-Wo Lee; I-Cheng Lu; Pi-Ying Chang; Pi-Jung Hsiao; Kuen-Yao Ho; Feng-Yu Chiang
Journal:  Head Neck       Date:  2012-09-18       Impact factor: 3.147

4.  Effect of intraoperative neuromonitoring on recurrent laryngeal nerve palsy rates after thyroid surgery--a meta-analysis.

Authors:  Shixing Zheng; Zhiwen Xu; Yuanyuan Wei; Manli Zeng; Jinnian He
Journal:  J Formos Med Assoc       Date:  2012-09-07       Impact factor: 3.282

5.  Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy.

Authors:  M Barczyński; A Konturek; S Cichoń
Journal:  Br J Surg       Date:  2009-03       Impact factor: 6.939

6.  Recurrent laryngeal nerve palsy after thyroidectomy with routine identification of the recurrent laryngeal nerve.

Authors:  Feng-Yu Chiang; Ling-Feng Wang; Yin-Feng Huang; Ka-Wo Lee; Wen-Rei Kuo
Journal:  Surgery       Date:  2005-03       Impact factor: 3.982

7.  Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.

Authors:  Chingmuh Lee; Jonathan S Jahr; Keith A Candiotti; Brian Warriner; Mark H Zornow; Mohamed Naguib
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

8.  Reversal of rocuronium-induced neuromuscular blockade by sugammadex allows for optimization of neural monitoring of the recurrent laryngeal nerve.

Authors:  I-Cheng Lu; Che-Wei Wu; Pi-Ying Chang; Hsiu-Ya Chen; Kuang-Yi Tseng; Gregory W Randolph; Kuang-I Cheng; Feng-Yu Chiang
Journal:  Laryngoscope       Date:  2016-01-09       Impact factor: 3.325

Review 9.  Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery.

Authors:  H Dralle; C Sekulla; K Lorenz; M Brauckhoff; A Machens
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

10.  Optimal depth of NIM EMG endotracheal tube for intraoperative neuromonitoring of the recurrent laryngeal nerve during thyroidectomy.

Authors:  I-Chen Lu; Koung-Shing Chu; Cheng-Jing Tsai; Che-Wei Wu; Wen-Rei Kuo; Hsiu-Ya Chen; Ka-Wo Lee; Feng-Yu Chiang
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

View more
  2 in total

1.  A Surgeon-Centered Neuromuscular Block Protocol Improving Intraoperative Neuromonitoring Outcome of Thyroid Surgery.

Authors:  I-Cheng Lu; Chiung-Dan Hsu; Pi-Ying Chang; Sheng-Hua Wu; Tzu-Yen Huang; Yi-Chu Lin; How-Yun Ko; Gianlorenzo Dionigi; Young Jun Chai; Feng-Yu Chiang; Yi-Wei Kuo; Che-Wei Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-10       Impact factor: 5.555

2.  Administration of neostigmine after tracheal intubation shortens time to successful intraoperative neuromonitoring during thyroid surgery: a randomized controlled trial.

Authors:  Moon Young Oh; Young Jun Chai; Tzu-Yen Huang; Che-Wei Wu; Gianlorenzo Dionigi; Hoon Yub Kim; Chanho Kim; Dongwook Won; Jung-Man Lee
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.